The Michael J. Fox Foundation has launched a new arm of their Parkinson’s Progression Markers Initiative (PPMI), studying at-risk populations in Parkinson’s Disease
The PPMI has completed enrollment of its initial 600-member cohort of Parkinson’s patients and controls, and is now launching additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson’s disease (PD).
The first of these new cohorts recent launched and will investigate risk factors for PD that may enable diagnosis before the onset of motor symptoms.
More information at the link below: